World Johnson & Johnson files for EU vaccine authorization

Johnson & Johnson files for EU vaccine authorization


- Advertisment -

648x415 vaccin johnson johnson administre seule dose efficace 66

Johnson & Johnson’s vaccine is given as a single dose but is only 66% effective. – SOPA Images / SIPA

The American pharmaceutical giant Johnson & Johnson has applied for authorization for its vaccine against Covid-19 in the European Union, the European Medicines Agency announced on Tuesday, adding that a decision was expected in March.

If given the green light from the Amsterdam-based agency, this single injection vaccine would be the fourth to be approved in the European Union.

A response expected mid-March 2021

“The EMA has received a marketing authorization application for a vaccine against Covid-19 developed by Janssen-Cilag International NV,” the agency said, referring to the European subsidiary of Johnson & Johnson. European experts “could issue an opinion in mid-March 2021, provided that the company’s data on the efficacy, safety and quality of the vaccine is sufficiently complete and convincing,” according to the EMA.

Johnson & Johnson’s vaccine has been under continuous evaluation by the EMA since December 1. The three vaccines authorized to date on the European market are those of AstraZeneca, Pfizer / BioNTech and Moderna. The European Commission has ordered 200 million doses of the vaccine from Johnson & Johnson, with an option for 200 million more. One hundred million doses must be delivered by June if the vaccine is approved.



Please enter your comment!
Please enter your name here

Latest news

- Advertisement -

Must read

- Advertisement -

You might also likeRELATED
Recommended to you